Showing results (171-180 of 506) with videos related to

Sort By:
Pageof 51
The Lancet. Infectious Diseases|March 28, 2013
Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care testStephen D Lawn, Peter Mwaba, Matthew Bates, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2015
B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in TuberculosisMartin Rao, Davide Valentini, Thomas Poiret, et al.
The European Respiratory Journal|August 8, 2015
Biomarkers for risk of developing active tuberculosis in contacts of TB patients: a prospective cohort studyNiaina Rakotosamimanana, Vincent Richard, Vaomalala Raharimanga, et al.
Clinical Microbiology Reviews|October 6, 2021
Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious DiseasesTimothy D Shaw, Anna D Krasnodembskaya, Gunnar N Schroeder, et al.
Cold Spring Harbor Perspectives in Medicine|March 30, 2026
Imaging Modalities in TuberculosisJamshed B Bomanji, Fawziah Alorfi, Sarah Algodayan, et al.
Lancet (London, England)|May 21, 2019
Mass gatherings medicine: public health issues arising from mass gathering religious and sporting eventsZiad A Memish, Robert Steffen, Paul White, et al.
Lancet (London, England)|October 18, 2002
Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trialAlwyn Mwinga, Andrew Nunn, Bagrey Ngwira, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 8, 2016
Impact of infectious disease epidemics on tuberculosis diagnostic, management, and prevention services: experiences and lessons from the 2014-2015 Ebola virus disease outbreak in West AfricaRashid Ansumana, Samuel Keitell, Gregory M T Roberts, et al.
Nature Reviews. Drug Discovery|February 13, 2016
Coronaviruses - drug discovery and therapeutic optionsAlimuddin Zumla, Jasper F W Chan, Esam I Azhar, et al.
British Journal of Pharmacology|November 6, 2020
Early or deferred initiation of efavirenz during rifampicin-based TB therapy has no significant effect on CYP3A induction in TB-HIV infected patientsEleni Aklillu, Alimuddin Zumla, Abiy Habtewold, et al.
Pageof 51